Complications of polyacrylamide gel filler in the Asian-Australian population A case series and literature review

Polyacrylamide gel (PAAG), known as Aquamid® (Contura Limited, London, United Kingdom, EC4A 1LB) in Australia, is a hydrophilic, non-toxic substance introduced in the 1970s as a soft tissue filler. Banned in the late 1990s due to concerns regarding side effects such as breast cancer and glandular at...

Full description

Saved in:
Bibliographic Details
Published inAustralasian journal of plastic surgery Vol. 2; no. 1; pp. 88 - 92
Main Authors Shen, Amanda Yang, Lin, Frank
Format Journal Article
LanguageEnglish
Published 15.03.2019
Online AccessGet full text

Cover

More Information
Summary:Polyacrylamide gel (PAAG), known as Aquamid® (Contura Limited, London, United Kingdom, EC4A 1LB) in Australia, is a hydrophilic, non-toxic substance introduced in the 1970s as a soft tissue filler. Banned in the late 1990s due to concerns regarding side effects such as breast cancer and glandular atrophy, there is currently no published data regarding PAAG fillers in the Australian literature. Given the increasing population of Chinese immigrants to Australia, complications will likely be seen more frequently within our healthcare system in the coming decades. This case series highlights two case in Australia with discussion of symptoms, signs and best-practice management.
ISSN:2209-170X
2209-170X
DOI:10.34239/ajops.v2i1.85